Texas 2025 - 89th Regular

Texas Senate Bill SB2257 Latest Draft

Bill / Introduced Version Filed 03/11/2025

Download
.pdf .doc .html
                            89R5865 MPF-D
 By: Cook S.B. No. 2257




 A BILL TO BE ENTITLED
 AN ACT
 relating to the definition and provision of an abortion-inducing
 drug.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 171.061(2), Health and Safety Code, is
 amended to read as follows:
 (2)  "Abortion-inducing drug" means a drug, a medicine,
 or any other substance, including a regimen of two or more drugs,
 medicines, or substances, prescribed, dispensed, or administered
 with the intent of terminating a clinically diagnosable pregnancy
 of a woman and with knowledge that the termination will, with
 reasonable likelihood, cause the death of the woman's unborn
 child.  The term includes off-label use of drugs, medicines, or
 other substances known to have abortion-inducing properties that
 are prescribed, dispensed, or administered with the intent of
 causing an abortion, including the Mifeprex regimen, and
 misoprostol (Cytotec)[, and methotrexate].  The term does not
 include a drug, medicine, or other substance that may be known to
 cause an abortion but is prescribed, dispensed, or administered for
 other medical reasons.
 SECTION 2.  Section 171.063(c), Health and Safety Code, is
 amended to read as follows:
 (c)  Before the physician provides an abortion-inducing
 drug, the physician must:
 (1)  examine the pregnant woman in person;
 (2)  independently verify that a pregnancy exists;
 (3)  [document, in the woman's medical record, the
 gestational age and intrauterine location of the pregnancy to
 determine whether an ectopic pregnancy exists;
 [(4)]  determine the pregnant woman's blood type, and
 for a woman who is Rh negative, offer to administer Rh
 immunoglobulin (RhoGAM) at the time the abortion-inducing drug is
 administered or used or the abortion is performed or induced to
 prevent Rh incompatibility, complications, or miscarriage in
 future pregnancies;
 (4) [(5)]  document whether the pregnant woman
 received treatment for Rh negativity, as diagnosed by the most
 accurate standard of medical care; and
 (5) [(6)]  ensure the physician does not provide an
 abortion-inducing drug for a pregnant woman whose pregnancy is more
 than 49 days of gestational age.
 SECTION 3.  (a) The changes in law made by this Act apply
 only to an offense committed on or after the effective date of this
 Act. An offense committed before the effective date of this Act is
 governed by the law in effect on the date the offense was committed,
 and the former law is continued in effect for that purpose. For
 purposes of this section, an offense was committed before the
 effective date of this Act if any element of the offense occurred
 before that date.
 (b)  The changes in law made by this Act apply only to the
 imposition of an administrative penalty for a violation that occurs
 on or after the effective date of this Act. The imposition of an
 administrative penalty for a violation that occurs before the
 effective date of this Act is governed by the law in effect on the
 date the violation occurred, and the former law is continued in
 effect for that purpose.
 SECTION 4.  This Act takes effect September 1, 2025.